BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17686315)

  • 21. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
    Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of KLK6 protein and mRNA in primary breast cancer and its clinical significance].
    Wang SM; Mao J; Li B; Wu W; Tang LL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1087-9. PubMed ID: 18992199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
    J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
    Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
    Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
    Chen L; Shen AG; Wang GL; Lu P; Li XY
    Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
    J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
    Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
    Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of MAGE-B genes in hepatocellular carcinoma].
    Mou DC; Leng XS; Peng JR; Zhao L; Wang WX; Wang Y; Li T; Zhang LG; Huang L; Zhu JY
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):40-2. PubMed ID: 15059354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
    Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of CXCR3 in hepatocellular carcinoma].
    Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
    Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of RhoA in progression of human hepatocellular carcinoma.
    Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.
    Kanda M; Nomoto S; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    J Surg Oncol; 2008 Sep; 98(3):190-6. PubMed ID: 18537151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of growth hormone receptor mRNA in hepatocellular carcinoma and matched para-cancer cirrhotic liver tissue].
    Wang HT; Wang J; Ou QJ; Liu XP; Chen S
    Ai Zheng; 2002 Feb; 21(2):146-8. PubMed ID: 12479063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis.
    Zhou Q; Huang T; Wang YF; Zhou XB; Liang LJ; Peng BG
    Chin Med J (Engl); 2011 Nov; 124(22):3746-51. PubMed ID: 22340235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.
    Li XR; Ji F; Ouyang J; Wu W; Qian LY; Yang KY
    Eur J Surg Oncol; 2006 Dec; 32(10):1130-4. PubMed ID: 16806792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
    Xiang X; Zhao WB; Wang X
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):661-4. PubMed ID: 19785952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
    Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
    Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.